bioAffinity Faces Losses While U.S. Global Investors Profits Surge

San Antonio, Monday, 24 November 2025.
bioAffinity Technologies reported a Q3 loss of $5.05 million, doubling last year’s deficit, while U.S. Global Investors saw a 378% profit surge, reflecting stark industry contrasts.